2
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Lymphoid
1
Conditions
Renal Insufficiency, Chronic
1
Renal Insufficiency
1
Lymphoma, Follicular
1
Heart Failure, Diastolic
1
Heart Failure
1
Breast Neoplasms
1
Interventions
Dexamethasone
13
Bortezomib
8
Cyclophosphamide
6
Lenalidomide
5
pomalidomide
3
isatuximab
3
glucarpidase
3
Kidney Transplantation
3
Calcium Dobesilate
3
Thalidomide
2
Paclitaxel
2
Gemcitabine
2
Carboplatin
2
Blood Specimen Collection
2
Bendamustine Hydrochloride
2
Azacitidine
2
vinflunine
1
veliparib
1
trifluridine tipiracil drug combination
1
trebananib
1
safinamide
1
sacubitril and valsartan sodium hydrate drug combination
1
rubitecan
1
ripretinib
1
regorafenib
1
pevonedistat
1
pembrolizumab
1
osimertinib
1
mirabegron
1
melflufen
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Renal Insufficiency
×
Eplerenone
×
Clear all
NCT07029503
2026-02-24
SCARF-1
Karolinska Institutet
Phase 2
Recruiting
40 enrolled